Skip to content

Advertisement

Alzheimer's Research & Therapy

What do you think about BMC? Take part in

Aims and scope

Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer's disease. An international peer-reviewed journal, it publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. The journal also provides reviews, viewpoints, commentaries, debates and reports.

Although the primary focus is Alzheimer's disease, the scope encompasses translational research into other neurodegenerative diseases.

Article image

Featured research article: Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases

"Minimally invasive specific biomarkers of neurodegenerative diseases (NDs) would facilitate patient selection and disease progression monitoring. We describe the assessment of circulating brain-enriched microRNAs as potential biomarkers for Alzheimer’s disease (AD)"

New Content Item

Featured commentary: The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer’s disease

"This commentary discusses the implications of disease-modifying treatments for Alzheimer’s disease which seem likely to appear in the next few years and results from a meeting of British experts in neurodegenerative diseases in Edinburgh... Since treatments are likely to be most effective in the early stages, identification of clinically relevant brain changes will be crucial."

Articles

  1. Content type: Research

      |  

    Authors: Susanne Ostrowitzki, Robert A. Lasser, Ernest Dorflinger, Philip Scheltens, Frederik Barkhof, Tania Nikolcheva, Elizabeth Ashford, Sylvie Retout, Carsten Hofmann, Paul Delmar, Gregory Klein, Mirjana Andjelkovic, Bruno Dubois, Mercè Boada, Kaj Blennow, Luca Santarelli…

View all articles
View all articles

Alzheimer's Disease International news

The World Health Organization (WHO) has unanimously adopted a global plan on dementia at the 70th session of the World Health Assembly in Geneva. The plan follows ten years of advocacy by ADI for a global response to the growing impact of dementia worldwide.

To read more about this global plan, please visit the ADI website here.

Latest Tweets

Editors-in-Chief

Alzheimer's Research & Therapy is edited by Philip Scheltens, Todd Golde and Doug Galasko. Find the full Editorial Board here.

Advertisement

Affiliated with

2016 Journal Metrics

Advertisement